Thus, elucidation of the molecular mechanisms of CRX effector domain truncating mutations will advance our understanding not only of CRX-linked retinal diseases but also of more general cellular processes such as mRNA surveillance pathways. The gene discussed is CRX; the disease is Abnormal retinal morphology.